Anxiety and dysautonomia symptoms in patients with a NaV1.7 mutation and the potential benefits of low-dose short-acting guanfacineRita de Cássia Collaço, Frank Bosmans, Maxime Lammens et al.|Clinical Autonomic Research|2023Cited by 9
Primary focal hyperhidrosis and autonomic symptom burden: a case–control study using the COMPASS-31 questionnaireAndrei Gurau, Malcolm Brock, Wasay Nizam et al.|Clinical Autonomic Research|2025Cited by 1
Supplementary Figure 2 from Cell Intrinsic Role of COX-2 in Pancreatic Cancer DevelopmentR. J. Hill, Hong Wu, Christine Kim et al.|Unknown|2023Cited by 0